CAS 20187-55-7

bendazac

Description:

Bendazac, with the CAS number 20187-55-7, is a chemical compound primarily recognized for its use as a non-steroidal anti-inflammatory drug (NSAID). It belongs to the class of compounds known as benzoic acid derivatives. Bendazac exhibits anti-inflammatory, analgesic, and antipyretic properties, making it useful in treating various inflammatory conditions. The compound is typically administered in topical formulations, particularly for conditions affecting the skin and joints. Its mechanism of action involves the inhibition of cyclooxygenase enzymes, which play a crucial role in the synthesis of prostaglandins, mediators of inflammation and pain. Bendazac is characterized by its moderate solubility in organic solvents and limited solubility in water, which influences its formulation and delivery methods. Safety and efficacy profiles are essential considerations in its use, and like other NSAIDs, it may have side effects, including gastrointestinal discomfort or allergic reactions in sensitive individuals. Overall, bendazac is a valuable compound in the pharmaceutical field, particularly for its therapeutic applications in managing pain and inflammation.

Formula: C₁₆H₁₄N₂O₃

InChI: InChI=1/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)

InChI key: InChIKey=BYFMCKSPFYVMOU-UHFFFAOYSA-N

SMILES: C(N1C=2C(C(OCC(O)=O)=N1)=CC=CC2)C3=CC=CC=C3

Synonyms:

• (1-Benzyl-1H-indazol-3-yloxy)-acetic acid
• (1-Benzyl-3-indazolyl)oxyacetic acid
• 1-Benzylindazole-3-oxyacetic acid
• 2-((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid
• 2-(1-Benzyl-1H-indazol-3-yloxy)acetic Acid
• 2-(1-Benzylindazol-3-yl)oxyacetic acid
• 2-[[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic acid
• 20187-55-7
• Acetic acid, [(1-benzyl-1H-indazol-3-yl)oxy]-
• Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
• Af 983
• Bendazolic Acid
• Bindazac
• Dogalina
• Zildasac
• Zildazac
• [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid
• [[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic Acid
• acetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
• Bendazac
• BENDAZAC AND ITS SODIUM SALT
• [[Benzyl-[1H]-indazol-3-yl] oxy] acetic acid
• AKOS 90683
• Versus

Bendazac

CAS: 20187-55-7

Formula: C₁₆H₁₄N₂O₃

Purity: >97.0%(GC)(T)

Color and Shape: White to Almost white powder to crystal

Molecular weight: 282.30

Ref: 3B-B4223

Acetic acid, 2-​[[1-​(phenylmethyl)​-​1H-​indazol-​3-​yl]​oxy]​-

CAS: 20187-55-7

Formula: C₁₆H₁₄N₂O₃

Purity: 95%

Color and Shape: Solid

Molecular weight: 282.2940

Ref: IN-DA0027WQ

Bendazac

CAS: 20187-55-7

Bendazac

Purity: ≥95%

Molecular weight: 282.29g/mol

Ref: 54-BUP17681

Bendazac

CAS: 20187-55-7

Formula: C₁₆H₁₄N₂O₃

Purity: ≥ 98.0%

Color and Shape: White powder

Molecular weight: 282.29

Ref: 7W-GP6732

2-(1-Benzyl-1H-indazol-3-yloxy)acetic Acid

CAS: 20187-55-7

2-(1-Benzyl-1H-indazol-3-yloxy)acetic Acid

Purity: 98%

Molecular weight: 282.29g/mol

Ref: 54-OR350059

Bendazac

CAS: 20187-55-7

Bendazac (Bendazolic acid) is an anticataract drug. It may act by preventing protein denaturation.

Formula: C₁₆H₁₄N₂O₃

Purity: 97.06%

Color and Shape: White To Off-White Crystalline Powder

Molecular weight: 282.29

Ref: TM-T7807

Bendazac

CAS: 20187-55-7

Formula: C₁₆H₁₄N₂O₃

Molecular weight: 282.30

Ref: 4Z-B-257001

Bendazac-d7

CAS: 20187-55-7

Formula: C₁₆H₇D₇N₂O₃

Molecular weight: 289.34

Ref: 4Z-B-257003

Bendazac - Bio-X ™

Controlled Product

CAS: 20187-55-7

Bendazac is a non-steroidal anti-inflammatory drug that is used for the treatment of cataracts and other inflammatory conditions such as hives and skin ulcers. Bendazac has an anti-cataract mechanism of action by inhibiting the denaturation of ocular lens proteins. Additionally, it has anti-necrotic and anti-lipidemic properties.

Formula: C₁₆H₁₄N₂O₃

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 282.29 g/mol

Ref: 3D-BB166154

Bendazac

Controlled Product

CAS: 20187-55-7

Xanthine oxidase inhibitor; anti-inflammatory agent; radical scavenger

Formula: C₁₆H₁₄N₂O₃

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 282.29 g/mol

Ref: 3D-FB18164

2-((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid

CAS: 20187-55-7

Formula: C₁₆H₁₄N₂O₃

Purity: 95%

Color and Shape: Solid

Molecular weight: 282.299

Ref: 10-F241193

Bendazac

Controlled Product

CAS: 20187-55-7

Applications Bendazac is a non-steroidal anti-inflammatory drug (NSAID). Bendazac is often used for joint and muscular pain. Bendazac has potential as an anti-denaturant drug for cataract and other condensation diseases as it protects proteins from denaturation induced by different agents.
References Silvestrini, B. et al.: Arzneim.-Forsch., 19, 30 (1969); Saso, L. et al.: Med. Hypoth., 56, 114 (2001); Saso, L. et al.: Arch. Pharm. Res., 24, 150 (2001);

Formula: C₁₆H₁₄N₂O₃

Color and Shape: Neat

Molecular weight: 282.29

Ref: TR-B132600

Bendazac

CAS: 20187-55-7

Formula: C₁₆H₁₄N₂O₃

Molecular weight: 282.3

Ref: ST-EA-CP-B474000